コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y (SPB) of budding yeast duplicates once per cell cycle.
2 tly incorporated in the mammalian genome per cell cycle.
3 nes were tightly linked to regulation of the cell cycle.
4 l metabolism, oxidative stress response, and cell cycle.
5 istones or histone PTMs in each stage of the cell cycle.
6 and subtle mass fluctuations throughout the cell cycle.
7 with cdk1 as the essential regulators of the cell cycle.
8 ation of gene transcription, DNA repair, and cell cycle.
9 overexpressed to study antiapoptosis and the cell cycle.
10 MP receptors and distinct modulations of the cell cycle.
11 molecule tracking in different phases of the cell cycle.
12 lated to B cell lineage, IL-7 signaling, and cell cycle.
13 s through regulation of the cytoskeleton and cell cycle.
14 n essential conserved role for DONSON in the cell cycle.
15 g factor of the unconventional P. falciparum cell cycle.
16 pend most of their life in interphase of the cell cycle.
17 ome organization and dynamics throughout the cell cycle.
18 litate passage to the succeding stage of the cell cycle.
19 early, mid, and late S phase of the mitotic cell cycle.
20 of gametocyte development in the subsequent cell cycle.
21 growth zone) display significantly different cell cycling.
22 P1 exhibit delays in growth of cell size and cell cycling.
23 erences in the cytokinin receptors mediating cell cycle activation in feeding sites induced by BCN an
24 tory protein that is itself inhibited by the cell-cycle activator, their interaction network presents
27 the majority of injury-induced cardiomyocyte cell cycle activity results in binucleation, not prolife
28 Stromal coculture did not prevent leukemia cell cycle activity, but a specific sensitivity profile
30 ining with anti-alpha-tubulin antibodies and cell cycle analysis indicated that tubulin and/or microt
31 nd break (DSB) repair pathway throughout the cell cycle and accounts for nearly all DSB repair outsid
32 nd 6 (CDK4/6) are fundamental drivers of the cell cycle and are required for the initiation and progr
33 and CDK6) regulate entry into S phase of the cell cycle and are validated targets for anticancer drug
35 ls of dNTPs are tightly regulated during the cell cycle and depend on the balance between dNTP biosyn
37 LXCXE-mimic) predicted to interact with the cell cycle and differentiation regulator RETINOBLASTOMA-
41 pathway delays cells in the G1 phase of the cell cycle and improves cell survival in response to gro
43 and comprised gene clusters associated with cell cycle and mitosis and with the presence or absence
49 ve/cytotoxic effects upon Caco-2 cells (MTT, cell cycle and reactive oxygen species (ROS)) were evalu
51 led to cell accumulation in G1 phase of the cell cycle and reduced expression of cell cycle regulato
53 esults establish a critical role of TRIB1 in cell cycle and survival that is mediated via the modulat
54 hat phospholipid metabolism is linked to the cell cycle and that changes in membrane composition can
55 SK stem cell population exhibiting increased cell cycling and a myelomonocytic differentiation bias.
58 survival, and further observe alterations in cell-cycle and immune checkpoint regulation genes in pos
60 in, which has roles including NE reassembly, cell cycle, and chromatin organization in cells, and sub
61 to transcription factors, neurogenesis, the cell cycle, and neuronal differentiation, and m(6)A tagg
62 sites, which are targeted by Cdks during the cell cycle, and that calcineurin opposes Fus3 to activat
63 uxin export, both preceding the induction of cell cycle- and cytoplasmic growth-associated genes.
66 ecule-1, calbindin), followed by a marker of cell cycle arrest (urine insulin-like growth factor-bind
67 liferation and colony formation, and induced cell cycle arrest accompanied by increased expression of
70 reatment with this enzyme selectively causes cell cycle arrest and death in cancer cells due to deple
74 kdown of FEN1 resulted in G1/S or G2/M phase cell cycle arrest and suppressed in vitro cellular proli
75 n and invasion as well as in vitro growth by cell cycle arrest at S phase with increased cell size an
76 iR-200a in metastatic melanoma cells induces cell cycle arrest by targeting CDK6 and decreases the le
80 t the RR inhibitor 3-AP actively induces PEL cell cycle arrest through inhibiting the activity of the
81 th drugs were mediated by induction of G0/G1 cell cycle arrest through upregulation of p27 and downre
83 lgae enter cellular quiescence, a reversible cell cycle arrest with drastic changes in metabolism all
84 s DNA damage, checkpoint activation, S-phase cell cycle arrest, and cell death in sensitive breast ca
85 cancer cells by inducing both apoptosis and cell cycle arrest, and that reducing DHX33 levels throug
86 ed in multiple cellular responses, including cell cycle arrest, DNA repair, apoptosis, metabolism, au
87 However, PI3K inhibitors primarily induce cell cycle arrest, leaving a significant reservoir of tu
88 tates and later antagonizes TGFbeta-mediated cell cycle arrest, yet remains critical for the patholog
96 e latter mechanism involves p38-dependent G1 cell-cycle arrest and subsequent intrinsic mitochondrial
99 and inactivates CRLs and, in turn, triggers cell-cycle arrest, apoptosis, senescence and autophagy i
100 ed ATR-dependent phosphorylation of Chk1 and cell-cycle arrest, consistent with replication checkpoin
102 these results establish circadian clock and cell cycle as interdependent coupled oscillators and ide
103 Ps) from categories including metabolism and cell cycle, as well as RNA- and protein-modifying enzyme
104 We reveal inducible changes in expression of cell cycle-associated proteins including MCM2 and cyclin
106 ts demonstrate how an evolutionary conserved cell cycle asynchrony maintains the invariant cleavage p
108 e propose that microRNA-200a functions as a "cell cycle brake" that is lost during melanoma progressi
109 tion is inhibited during the G1 phase of the cell cycle, but both pathways are active in the S and G2
111 ability of ATR inhibition to abrogate the G2 cell cycle checkpoint both contributed to the synergisti
112 We showed here that E7 abrogated the G1 cell cycle checkpoint under hypoxia and analyzed key cel
113 igger a characteristic 'VSG synthesis block' cell-cycle checkpoint, as some cells reinitiated S phase
114 ys that maintain genomic stability including cell cycle checkpoints, DNA repair, protein ubiquitinati
117 vealed upregulation of genes associated with cell cycle, chromatin, cytoskeleton/motility, immunity,
119 d recovery from anemic stress and persistent cell cycling consistent with a role for KLF3 in dampenin
121 s regulating diverse cellular processes from cell cycle control to developmental fate, deregulation o
122 tumour suppressor gene), CDC14B (involved in cell cycle control) and NTRK3 (tyrosine receptor kinase
123 ss, impaired checkpoint signaling, defective cell cycle control, and genomic instability, which was r
124 ppression of DNA damage signaling is key for cell-cycle control and needed for normal development.
126 rough suppression of the transcriptional and cell cycle defects was observed upon depletion of the ce
129 le progression in human cells, and it causes cell-cycle deficits of radial glial cells in the embryon
130 Here, we investigate size control and the cell cycle dependence of bacterial growth using multigen
133 and opens up tremendous scope for analysing cell cycle dynamics and developing interventions targett
134 e fungal pathogen Candida albicans to couple cell cycle dynamics with responses to cell wall stress i
138 re report that SOCE and calcineurin regulate cell cycle entry of quiescent T cells by controlling gly
140 In normal cells, Ki-67 was a late marker of cell-cycle entry; Ki-67 mRNA oscillated with highest lev
141 ns how these larger fluctuations in archaeal cell cycle events contribute to cell size variability an
142 fication that can be used to fine-tune these cell cycle events, frequently through processes that do
145 ing this approach, we found that Gsx2 delays cell-cycle exit and reduces Pax6 expression, whereas Ebf
154 ne expression studies point to regulation of cell cycle genes, muscle myosins, NotchR and Wnt pathway
156 MOS1 and TCP15 both affect the expression of cell-cycle genes D-type CYCLIN 3;1 (CYCD3;1), which may
159 ssociated with cell death and impacts on the cell cycle in three dinoflagellate species (Prorocentrum
160 nd interferon (IFN) pathways, which enforced cell cycling in quiescent HSPCs, resulting in their apop
161 promoter among G1 and G2/M cells, suggesting cell cycle-independent origin of cell-to-cell variation
163 KLF2 transcription factor or the CDKN1B/p27 cell cycle inhibitor are recurrent in 16% of patients wi
164 ssion studies revealed that induction of the cell cycle inhibitor Cdkn1a was responsible for the decr
167 in Arabidopsis by directly upregulating the cell-cycle inhibitor KRP2 in the underlying rib meristem
171 ed by the transcriptional stimulation of the cell-cycle inhibitory protein p21(Waf1/Cip1) Consistentl
173 for regulating PD-L1 protein stability by a cell cycle kinase and reveals the potential for using co
174 , the total numbers of type 1 node proteins (cell cycle kinases Cdr1p, Cdr2p, Wee1p, and anillin Mid1
175 al, but whereas inhibitors of chaperones and cell cycle kinases induce similar transcriptional change
178 naling genes and down-regulation of the G2/M cell-cycle marker gene, CYCB1;1 TCP20 and NLP6&7 also su
179 by mitogens and accompanied by induction of cell-cycle markers, including phosphorylation of the ret
180 cues, which overall entails a modulation of cell cycle, meiosis-related and nutrient transporter gen
181 ssifier, including those involved in mitotic cell cycle, microtubule organization, and chromosome seg
182 ingle-cell microscopy to parameterize a full cell-cycle model based on independent control of pre- an
185 a neural progenitor cell (NPC) reenters the cell cycle or exits and differentiates are pivotal for g
187 inogenic role of NOTCH in vivo Alteration of cell cycle pathways was seen in murine renal tubular cel
188 ase, vascular endothelial growth factor, and cell cycle pathways, whereas esophageal squamous tumors
189 embryos fail to initiate timely MZT, undergo cell-cycle pause, and remain developmentally delayed thr
191 ndependent regulation of pre- and post-Start cell-cycle periods rather than the consequence of an und
193 th a high proportion of cells in a quiescent cell cycle phase as assessed in wounds, tumors, and aort
199 least in part, to reversible pausing of the cell cycle preventing S phase associated DNA damage.
201 g cell cycle indexes that measure changes in cell cycle profile patterns upon chemical perturbation,
203 l outcomes have been attributed to increased cell cycle progression and the development of genomic in
206 cyclin-dependent kinase 2 (CDK2), regulates cell cycle progression as cells exit quiescence and ente
207 the CaMKK-like protein kinase Ssp1 promotes cell cycle progression by activating the ARK Cdr2 accord
208 t kinase (CDK) inhibitor p27, which inhibits cell cycle progression by binding cyclin A- and cyclin E
209 ular phenotype was observed while monitoring cell cycle progression in cells lacking MCPH1 function.
211 the dynamics of chromosome condensation and cell cycle progression in MCPH1 deficient cells under un
213 s an indirect regulator of transcription and cell cycle progression through the regulation of specifi
214 GH3 cell proliferation through induction of cell cycle progression via activation of the Akt-GSK-3be
215 that mechanisms regulating mRNA translation, cell cycle progression, and gene expression differ from
216 ny formation, elicited S phase arrest during cell cycle progression, and induced both intrinsic and e
217 scription factor FoxM1 plays a vital role in cell cycle progression, is activated in numerous human m
219 letal metabolism, intracellular trafficking, cell cycle progression, repair/maintenance, bioenergetic
220 cation, telomere maintenance and elongation, cell cycle progression, signal transduction and cell pro
229 unctions non-cell-autonomously to facilitate cell-cycle progression and stem cell proliferation.
230 tein 3 (IGFBP3), and that this regulates SCC cell-cycle progression and tumor growth in vivo Furtherm
231 prolongs mitotic length and interferes with cell-cycle progression in human cells, and it causes cel
233 to DZ proliferation rather than for allowing cell-cycle progression itself and must be regulated dyna
234 chanisms of PI3Kalpha and CDK4/6 blockade on cell-cycle progression, DNA damage response, and immune-
235 oss of pigmentation, and melanoblasts showed cell-cycle progression, migration, and cytokinesis defec
236 processes, including cytoskeletal dynamics, cell-cycle progression, signal transduction, gene expres
241 in ligation, and increased the expression of cell cycle-promoting cyclin proteins, without enhancing
242 miRNA family causes derepression of multiple cell cycle-promoting proteins, thereby preventing epithe
243 SP-7, DFF-45, NPM, YWHAZ, Src, PAX2, MAPK8), cell cycle promotion and cancer progression (CDK1, CDK2,
246 facilitate robust and long-term depletion of cell-cycle proteins and reveals insights into the requir
252 ng Xenopus egg extract, we show that direct, cell-cycle-regulated binding of M18BP1 to CENP-A nucleos
253 of Fun30 to DSBs is sufficient to bypass the cell cycle regulation of long-range resection, indicatin
254 onverge on aspects of cell proliferation and cell cycle regulation, including DNA synthesis (NPAT), D
255 Furthermore, one pathway that is involved in cell cycle regulation, REACTOME_CHROMOSOME _MAINTENANCE,
256 y involved in diverse biological signals and cell-cycle regulation although further replication in a
258 ates at specific enhancer regions of the key cell cycle regulator Cdkn1a and the stem cell regulator
259 lerosis through, at least in part, targeting cell cycle regulator cyclin A and connective tissue grow
260 Vasculature proliferation also involves the cell cycle regulator KIP-RELATED PROTEIN2 and ABERRANT L
262 th an increased expression of p21cip1/waf, a cell cycle regulator that is involved in the differentia
264 KDM5-activated genes include a large set of cell cycle regulators and that the KDM5s are necessary f
265 of the cell cycle and reduced expression of cell cycle regulators during the initiation stage of rep
267 Z/YAP promote SC proliferation by activating cell cycle regulators, while targeting critical differen
268 Here, we demonstrate the application to cell cycle regulatory network analysis for Saccharomyces
270 le checkpoint under hypoxia and analyzed key cell cycle related proteins for their potential role in
271 ivity, but a specific sensitivity profile to cell cycle-related drugs identified samples with higher
273 In this study, we determine the functions of cell cycle-related kinase (CDK20) in radiochemoresistanc
274 Our results suggest that overexpression of cell-cycle-related genes are a characteristic of prolife
281 pervised manner and, in classifying discrete cell cycle stages, we reach a sixfold reduction in error
282 i-C data to separate cells by karyotypic and cell-cycle state differences and identify cell-to-cell h
286 vidence suggests that LBH could modulate the cell cycle, the precise mechanism is unknown and its imp
287 rs have emerged as the most promising of the cell-cycle therapeutics and intense efforts are now unde
289 nd cyclin A to stage individual cells in the cell cycle to determine the levels of histones or histon
290 aberrant genetic materials often causes the cell cycle to go awry, leading to malignant transformati
292 d transduces multiple signals to control key cell-cycle transitions during Plasmodium gametogenesis.
294 le genes involved in maintaining the mitotic cell cycle were rapidly down-regulated and senescence ge
296 e defined as a distinct state outside of the cell cycle while displaying a sequential cell order refl
297 rogressing synchronously through the mitotic cell cycle, while preserving the coupling of cell divisi
298 G1 subpopulations that progress through the cell cycle with distinct temporal profiles post-elutriat
299 ells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clon
300 ate a molecular difference in the control of cell cycle withdrawal in fetal and postnatal myogenic st
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。